Sequent Scientific Limited announced that the Board of Directors of the Company has taken on record/approved the following changes in the composition of the Board of Directors at its meeting held on January 14, 2022: Mr. Manish Gupta resigned as a Managing Director (MD) of the Company with effect from April 10, 2022. Mr. Rajaram Narayanan appointed as MD of the Company for a period of 5 years, with effect from April 11, 2022. The appointment is subject to the approval of shareholders of the Company, which shall be sought separately.

Mr. Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Mr. Manish Gupta who will be stepping down effective April 10, 2022 after serving as MD and CEO of the Company for past eight years.